✦ LIBER ✦

How are bisphosphonates used today in breast cancer clinical practice?

✍ Scribed by Catherine Van Poznak

Book ID: 114105400
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 727 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)90236-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using neoadjuvant therapy for breast can

Using neoadjuvant therapy for breast cancer in clinical practice: when and how?

✍ Debu Tripathy 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 103 KB

Biochemical markers in breast cancer: wh

Biochemical markers in breast cancer: which ones are clinically useful?

✍ M.J Duffy 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Genetic and epigenetic alterations in br

Genetic and epigenetic alterations in breast cancer: What are the perspectives for clinical practice?

✍ Alfredo Fucito; Chiara Lucchetti; Antonio Giordano; Gaetano Romano 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Adjuvant bisphosphonate treatment for br

Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?

✍ Kent Russell; Mark Clemons; Luis Costa; Christina L. Addison 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 420 KB

Use in current clinical practice of 70-g

Use in current clinical practice of 70-gene signature in early breast cancer

✍ Claudia Bighin; Lucia Del Mastro; Giuseppe Canavese; Franca Carli; Paola Taveggi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

One of the aims of gene expression profiling is to identify early breast cancer patients with a good prognosis who can avoid adjuvant chemotherapy. 1 In our Institute, we obtained a 70-gene signature (Mamma Print) 2 on 21 early breast cancer patients. All patients gave written informed consent appro

Speaker against: are we ready to use tam

Speaker against: are we ready to use tamoxifen to prevent breast cancer in daily practice?

✍ T.J. Powles 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 57 KB